blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2310860

EP2310860 - BLOOD GLUTATHIONE AS A BIOMARKER FOR SCREENING ASYMPTOMATIC PATIENTS AT RISK FOR HEART FAILURE [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  01.11.2013
Database last updated on 03.10.2024
Most recent event   Tooltip01.11.2013Application deemed to be withdrawnpublished on 04.12.2013  [2013/49]
Applicant(s)For all designated states
INSERM - Institut National de la Santé et de la Recherche Médicale
101, rue de Tolbiac
75013 Paris / FR
[2011/16]
Inventor(s)01 / DAMY, Thibaud
U955 INSERM Institut Mondor de Recherche Biomédicale Hôpital Henri Mondor 51 Avenue du Maréchal De Lattre De Tassigny
F-94010 Créteil / FR
02 / LE CORVOISIER, Philippe
U955 INSERM Institut Mondor de Recherche Biomédicale Hôpital Henri Mondor 51 Avenue du Maréchal De Lattre De Tassigny
F-94010 Créteil / FR
03 / PAVOINE, Catherine
U955 INSERM Institut Mondor de Recherche Biomédicale Hôpital Henri Mondor 51 Avenue du Maréchal De Lattre De Tassigny
F-94010 Créteil / FR
04 / PECKER, Françoise
U955 INSERM Institut Mondor de Recherche Biomédicale Hôpital Henri Mondor 51 Avenue du Maréchal De Lattre De Tassigny
F-94010 Créteil / FR
05 / CARAMELLE, Philippe
U955 INSERM Institut Mondor de Recherche Biomédicale Hôpital Henri Mondor 51 Avenue du Maréchal De Lattre De Tassigny
F-94010 Créteil / FR
 [2011/16]
Representative(s)Plasseraud IP
104 Rue de Richelieu
CS92104
75080 Paris Cedex 02 / FR
[N/P]
Former [2011/16]Cabinet Plasseraud
52, rue de la Victoire
75440 Paris Cedex 09 / FR
Application number, filing date09802484.717.07.2009
[2011/16]
WO2009EP59242
Priority number, dateEP2008030543830.07.2008         Original published format: EP 08305438
[2011/16]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2010012616
Date:04.02.2010
Language:EN
[2010/05]
Type: A1 Application with search report 
No.:EP2310860
Date:20.04.2011
Language:EN
The application published by WIPO in one of the EPO official languages on 04.02.2010 takes the place of the publication of the European patent application.
[2011/16]
Search report(s)International search report - published on:EP04.02.2010
ClassificationIPC:G01N33/68, G01N33/53
[2011/16]
CPC:
G01N33/6893 (EP,US); A61P9/04 (EP); G01N2800/325 (EP,US);
G01N2800/50 (EP,US)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   SM,   TR [2011/16]
TitleGerman:BLUTGLUTATHION ALS BIOMARKER ZUR UNTERSUCHUNG ASYMPTOMATISCHER HERZINFARKT-GEFÄHRDETER PATIENTEN[2011/16]
English:BLOOD GLUTATHIONE AS A BIOMARKER FOR SCREENING ASYMPTOMATIC PATIENTS AT RISK FOR HEART FAILURE[2011/16]
French:GLUTATHION SANGUIN COMME BIOMARQUEUR POUR LE DÉPISTAGE DE PATIENTS ASYMPTOMATIQUES PRÉSENTANT UN RISQUE D'INSUFFISANCE CARDIAQUE[2011/16]
Entry into regional phase10.01.2011National basic fee paid 
10.01.2011Designation fee(s) paid 
10.01.2011Examination fee paid 
Examination procedure10.01.2011Amendment by applicant (claims and/or description)
10.01.2011Examination requested  [2011/16]
14.02.2013Despatch of a communication from the examining division (Time limit: M04)
25.06.2013Application deemed to be withdrawn, date of legal effect  [2013/49]
31.07.2013Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2013/49]
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  14.02.2013
Fees paidRenewal fee
29.07.2011Renewal fee patent year 03
23.07.2012Renewal fee patent year 04
Penalty fee
Additional fee for renewal fee
31.07.201305   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[I]WO2005046675  (HOLTZMAN JORDAN [US]) [I] 9 * page 1, lines 31-34; page 2, lines 1-5; page 2, lines 26-34; page 3, lines 1-6; page 22, claim 1 *;
 [XY]US2005202521  (CRUM ALBERT [US]) [X] 5 * paragraphs 0001, 0013-0019,0313-0314, 0210-0211; claim 1. *[Y] 1-4,6-8;
 [Y]US2006105419  (BLANKENBERG STEFAN [DE], et al) [Y] 1-4,6-8 * paragraphs 0002, 0004, 0005, 0010, 0011, 0021-0024, 0030, 0031, 0040-0053, 0057, 0070-0075, 0077; page 17, claims 1-6, 13-22, 26, 27. *;
 [IDY]  - ADAMY ET AL, "Neutral sphingomyelinase inhibition participates to the benefits of N-acetylcysteine treatment in post-myocardial infarction failing heart rats", JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, ACADEMIC PRESS, GB, (20070827), vol. 43, no. 3, ISSN 0022-2828, pages 344 - 353, XP022214894 [ID] 9 * the whole document * [Y] 1-4,6-8

DOI:   http://dx.doi.org/10.1016/j.yjmcc.2007.06.010
 [Y]  - NIELSEN OLAV W ET AL, "Retrospective analysis of the cost-effectiveness of using plasma brain natriuretic peptide in screening for left ventricular systolic dysfunction in the general population.", JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY 1 JAN 2003, (20030101), vol. 41, no. 1, ISSN 0735-1097, pages 113 - 120, XP002503275 [Y] 2,6 * the whole document *

DOI:   http://dx.doi.org/10.1016/S0735-1097(02)02625-6
 [Y]  - AL-MALLAH MOUAZ ET AL, "POSITIVE TROPONIN IN DIABETIC KETOACIDOSIS WITHOUT ACUTE CORONARY SYNDROME PREDICTS POOR OUTCOME", CIRCULATION, AMERICAN HEART ASSOCIATION, DALLAS, TX, (20041001), vol. 110, no. 17, SUPPL.S, ISSN 0009-7322, page 413(ABSTRACT1948), XP008069195 [Y] 2,6 * the whole document *
 [Y]  - SHARMA RAKESH ET AL, "Elevated circulating levels of inflammatory cytokines and bacterial endotoxin in adults with congenital heart disease.", THE AMERICAN JOURNAL OF CARDIOLOGY 15 JUL 2003, (20030715), vol. 92, no. 2, ISSN 0002-9149, pages 188 - 193, XP002503276 [Y] 2-3,6-7 * the whole document *

DOI:   http://dx.doi.org/10.1016/S0002-9149(03)00536-8
 [Y]  - RAUCHHAUS M ET AL, "Plasma cytokine parameters and mortality in patients with chronic heart failure.", CIRCULATION 19 DEC 2000, (20001219), vol. 102, no. 25, ISSN 1524-4539, pages 3060 - 3067, XP002503277 [Y] 2-3,6-7 * the whole document *
 [XY]  - BIOVISION, INC, "ApoGSH tm Glutathione Fluorometric/Colormetric Assays", PRODUCT INFO, (20070304), URL: http://web.archive.org/web/20070304054209/http://www.biovision.com/updated/gluthathione.html, (20090921), XP002546616 [X] 5 * the whole document * [Y] 6-7
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.